ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 20 filers reported holding ENZYMOTEC LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $7,616,000 | +75.7% | 642,700 | +69.8% | 0.01% | +60.0% |
| Q3 2017 | $4,334,000 | +78.9% | 378,500 | +26.6% | 0.01% | +66.7% |
| Q2 2017 | $2,422,000 | -4.7% | 299,000 | +3.6% | 0.00% | -25.0% |
| Q1 2017 | $2,541,000 | +33.7% | 288,700 | -0.4% | 0.00% | +33.3% |
| Q4 2016 | $1,900,000 | +5.1% | 290,000 | +12.3% | 0.00% | 0.0% |
| Q3 2016 | $1,808,000 | -10.3% | 258,300 | +7.2% | 0.00% | -25.0% |
| Q2 2016 | $2,015,000 | +23.3% | 241,000 | +33.1% | 0.00% | +33.3% |
| Q1 2016 | $1,634,000 | -23.4% | 181,000 | -16.9% | 0.00% | -40.0% |
| Q4 2015 | $2,133,000 | +61.5% | 217,700 | +49.1% | 0.01% | +66.7% |
| Q3 2015 | $1,321,000 | +91.7% | 146,000 | +77.0% | 0.00% | +50.0% |
| Q2 2015 | $689,000 | +76.7% | 82,494 | +52.2% | 0.00% | +100.0% |
| Q1 2015 | $390,000 | – | 54,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 202,962 | $5,482,000 | 1.66% |
| Visium Asset Management, LP | 690,000 | $18,637,000 | 0.37% |
| ALYDAR PARTNERS LLC | 90,000 | $2,431,000 | 0.25% |
| Paulson & Co. | 1,733,030 | $46,809,000 | 0.23% |
| GILDER GAGNON HOWE & CO LLC | 218,232 | $5,894,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 83,971 | $2,268,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 10,000 | $270,000 | 0.04% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 5,450 | $148,000 | 0.03% |
| TFS CAPITAL LLC | 9,736 | $263,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 208,806 | $5,640,000 | 0.01% |